Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. (HOTH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HOTH · as of Sep 30, 2025
Ownership Breakdown
24
Institutional Holders
▲ 10 vs Q2
$2.16M
Total Inst. Value
▲ $1.85M vs Q2
13.26M
Shares Outstanding
freeFloat 95.83%
1.34M
13F Shares Held
▲ 1.07M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HOTH largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 243.9K | 1.85% | 1.85% | $395.15M | Nov 13, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 214.0K | 1.62% | 1.62% | $346.69M | Nov 7, 2025 | ▲ 175.2K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 153.5K | 1.16% | 1.16% | $248.73M | Nov 12, 2025 | ▲ 31.0K |
CITADEL ADVISORS LLC pharmaceutical preparations | 143.5K | 1.09% | 1.09% | $232.43M | Nov 14, 2025 | NEW |
VIRTU FINANCIAL LLC pharmaceutical preparations | 113.4K | 86.05% | 86.05% | $184.00M | Nov 14, 2025 | ▲ 113.4K |
UBS GROUP AG pharmaceutical preparations | 94.7K | 71.82% | 71.82% | $153.36M | Nov 13, 2025 | ▲ 52.4K |
HRT FINANCIAL LP pharmaceutical preparations | 85.3K | 64.74% | 64.74% | $138.00M | Nov 14, 2025 | ▲ 85.3K |
STATE STREET CORP pharmaceutical preparations | 63.9K | 48.51% | 48.51% | $103.58M | Nov 14, 2025 | NEW |
JANE STREET GROUP, LLC pharmaceutical preparations | 54.9K | 41.68% | 41.68% | $89.00M | Nov 14, 2025 | NEW |
NORTHERN TRUST CORP pharmaceutical preparations | 41.5K | 31.49% | 31.49% | $67.24M | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
10
Increased
+493.7K shares9
New Positions
first time holders2
Decreased
−5.9K shares2
Sold Out
fully exitedNet shares change (top 50)
+487.8K
+493.7K / −5.9K
Net new holders
+15
9 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HOTH insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
1
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Hoth Therapeutics, Inc. (HOTH) is primarily owned by institutional investors, who hold approximately 10.1% of total shares outstanding. Company insiders own approximately 4.17%, while retail and public investors account for the remaining 85.76%.
The largest institutional shareholder of Hoth Therapeutics, Inc. is RENAISSANCE TECHNOLOGIES LLC, holding approximately 243,921 shares — equal to 1.85% of outstanding shares — as of September 30, 2025.
A total of 24 institutional investors currently hold HOTH stock, with a combined institutional value of approximately $2,161,606 as of the most recent 13F filing period.
Frequently asked questions
HOTH ownershipHoth Therapeutics, Inc. (HOTH) is primarily owned by institutional investors, who hold approximately 10.1% of shares. The largest shareholder is RENAISSANCE TECHNOLOGIES LLC with a 1.85% stake. Company insiders hold 4.17%. Data sourced from SEC Form 13F as of September 30, 2025.